Large-capacity Newcastle disease live vaccine 'Poulshot ND Max' launched

게시됨 2026년 2월 2일

Tridge 요약

[Livestock News Reporter Kim Young-gil] The Central Vaccine Research Institute (CEO Yoon In-jung) has launched a high-capacity 5,000 titer New Castle Disease (ND) live vaccine, 'Poulshot ND Max'. 'Poulshot ND Max' has increased the capacity from the previous 2,000 titer product to 5,000 titers. This not only reduces the volume and weight of the vaccine but also decreases the disposal rate of empty bottles after vaccine use by approximately 60%. 'Poulshot ND Max' is a long

원본 콘텐츠

[Livestock News, Kim Young-gil Reporter] The Central Vaccine Research Institute (Representative Yoon In-jung) has launched a high-capacity 5,000-dose Newcastle Disease (ND) live vaccine, 'Poulshot ND Max'. 'Poulshot ND Max' has increased the capacity from the previous 2,000 doses to 5,000 doses. This not only reduces the volume and weight of the vaccine but also decreases the disposal rate of empty bottles after vaccine use by approximately 60%. 'Poulshot ND Max' incorporates an enterotrophic Newcastle Disease vaccine strain that acts briefly on the respiratory system and acts longer in the digestive system (intestines), significantly reducing respiratory stress. The Central Vaccine Research Institute stated, ...
출처: Chuksannews

더 깊이 있는 인사이트가 필요하신가요?

귀사의 비즈니스에 맞춤화된 상세한 시장 분석 정보를 받아보세요.
'쿠키 허용'을 클릭하면 통계 및 개인 선호도 산출을 위한 쿠키 제공에 동의하게 됩니다. 개인정보 보호정책에서 쿠키에 대한 자세한 내용을 확인할 수 있습니다.